Placenta Accreta Spectrum in delivered women is associated with history of curettage: A case-control study at Dr. Moewardi General Hospital, Surakarta, Indonesia
Downloads
HIGHLIGHTS
- Placenta Accreta Spectrum cases rise in proportion to the high frequency of uterine wall damage.
- A significant association was found between curettage history and Placenta Accreta Spectrum.
ABSTRACT
Objective: Placenta Accreta Spectrum (PAS) is a condition in which the placental villi directly adhere to the myometrium, a leading cause of serious obstetric bleeding. The situation has increased morbidity and mortality in pregnant women due to 3.000 – 5.000 mL blood loss. The incidence of PAS has risen globally from 0.12% to 0.31%, linked to frequent uterine damage from procedures like cesarean sections or curettage. This study aims to determine the association between history of curettage and PAS.
Materials and Methods: The type of research used is analytic observational with a case-control approach. The sampling technique used in this study is purposive sampling, and 134 samples match the inclusion criteria. The samples used are delivered women referred to Dr. Moewardi General Hospital, Surakarta, Indonesia, from May 2022 until May 2024. Data analysis utilizing IBM SPSS 25. Chi-square test determines the association between two variables at a significance level of p < 0.05, while logistic regression is used to determine the most influential variables.
Results: The sample consisted of 67 patients with PAS and 67 without PAS. There was a significant association between the history of curettage and PAS, as determined by a Chi-square test, with a p-value of 0.000. Further analysis using logistic regression on the history of curettage obtained a value of p = 0.001 and OR = 5.769 (CI95% 2.090 – 15.928).
Conclusion: The history of curettage is significantly associated with PAS. Patients who have had curettage in the past are 5.769 times more likely to experience PAS than patients without a history of curettage.
Arifin Z. Implementasi Pelayanan Kesehatan dalam Penurunan Angka Kematian Ibu. Jurnal Penelitian Kesehatan “SUARA FORIKES” (Journal of Health Research “Forikes Voice”). 2023 Jan 9;14(1):6–10. doi: 10.33846/sf14102.
Badan Pusat Statistik Provinsi Jawa Tengah. Hasil Long Form Sensus Penduduk 2020 Provinsi Jawa Tengah [Internet]. Badan Pusat Statistik Provinsi Jawa Tengah; 2020 [cited 2024 Aug 24]. Available from: https://jateng.bps.go.id/publication/2023/02/10/5b211edf75a0b50a74c56264/hasil-long-form-sensus-penduduk-2020-provinsi-jawa-tengah.html.
Agarwal S, Ranjan M, Sachan S, et al. Antepartum hemorrhage and its maternal and perinatal outcome: An experience at a hospital in North India. Journal of family medicine and primary care. 2023 Dec 21;12(12):3204–8. doi: 10.4103/jfmpc.jfmpc_692_23. PMID: 38361908; PMCID: PMC10866261.
Beyene BN, Boneya DJ, Adola SG, et al. Factors associated with postpartum hemorrhage in selected Southern Oromia hospitals, Ethiopia, 2021: an unmatched case-control study. Frontiers in global women’s health. 2024 Mar 14;5. doi: 10.3389/fgwh.2024.1332719. PMID: 38549584; PMCID: PMC10972879.
Ramadhan JW, Rasyid R, Rusnita D. Profil Pasien Hemorrhagic Postpartum di RSUP Dr. M. Djamil Padang. Jurnal Kesehatan Andalas. 2024;8(2S):46–53. doi: 10.25077/jka.v8i2S.958.
Utami NA, Amirsyah M, Indirayani I, et al. Gambaran kejadian perdarahan post partum di RSUDZA Banda Aceh Tahun 2019-2020. Jurnal Kedokteran Syiah Kuala. 2022;22(3):20–5. doi: 10.24815/jks.v22i3.25157.
El Gelany S, Mosbeh MH, Ibrahim EM, et al. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study. BMC Pregnancy and Childbirth. 2019 Aug 27;19(1):313–20. doi: 10.1186/s12884-019-2466-5. PMID: 31455286; PMCID: PMC6712589.
Mirani P, Lestari PM, Murti K, et al. Placenta accreta spectrum disorder: An updated literature review. JKKI: Jurnal Kedokteran dan Kesehatan Indonesia. 2023 Dec 30;14(3):344–56. doi: 10.20885/JKKI.Vol14.Iss3.art15.
Morlando M, Collins S. Placenta Accreta Spectrum Disorders: Challenges, Risks, and Management Strategies. International Journal of Women’s Health. 2020 Nov 10;12:1033–45. doi: 10.2147/IJWH.S224191. PMID: 31455286; PMCID: PMC6712589.
Imafuku H, Tanimura K, Shi Y, et al. Clinical factors associated with a placenta accreta spectrum. Placenta. 2021 Sep 1;112:180–4. doi: 10.1016/j.placenta.2021.08.001. PMID: 34375912.
Dawood A, Elsokary A, Shazly S. Association Between Characteristics of Patients having A Previous Cesarean Delivery and the Presence of Placenta Accreta Spectrum: A Case-Control Study. Evidence Based Women’s Health Journal. 2023 Aug 1;13(3):303–10. doi: 10.21608/ebwhj.2023.214406.1253.
Pegu B, Thiagaraju C, Nayak D, et al. Placenta accreta spectrum-a catastrophic situation in obstetrics. Obstetrics & Gynecology Science. 2021 May 15;64(3):239–47. doi: 10.5468/ogs.20345. PMID: 33757280; PMCID: PMC8138076.
Hussein AM, Elbarmelgy RA, Elbarmelgy RM, et al. Prospective evaluation of impact of post?Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder. Ultrasound in Obstetrics & Gynecology. 2022 Mar 8;59(4):474–82. doi: 10.1002/uog.23732. PMID: 34225385; PMCID: PMC9311077.
Soares MJ, Iqbal K, Kozai K. Hypoxia and Placental Development. Birth Defects Research. 2017 Oct 16;109(17):1309–29. doi: 10.1002/bdr2.1135. PMID: 29105383; PMCID: PMC5743230.
Dahlan MS. Besar Sampel dan Cara Pengambilan Sampel dalam Penelitian Kedokteran dan Kesehatan. Jakarta: Salemba Medika; 2016. p. 46–60.
You H, Wang Y, Han R, et al. Risk factors for placenta accreta spectrum without prior cesarean section: A case–control study in China. International journal of gynaecology and obstetrics. 2024 Apr 4;166(3):1092–9. doi: 10.1002/ijgo.15493. PMID: 38573157.
Baldwin HJ, Patterson JA, Nippita TA, et al. Antecedents of Abnormally Invasive Placenta in Primiparous Women. Obstetrics & Gynecology. 2018 Feb;131(2):227–33. doi: 10.1097/aog.0000000000002434. PMID: 29324602.
Burke SD, Zsengellér ZK, Karumanchi SA, et al. A mouse model of placenta accreta spectrum. Placenta. 2020 Sep;99:8–15. doi: 10.1016/j.placenta.2020.06.006. PMID: 32716845.
Rac MWF, Dashe JS, Wells CE, et al. Ultrasound predictors of placental invasion: the Placenta Accreta Index. American Journal of Obstetrics and Gynecology. 2015 Mar;212(3):343.e1–7. doi: 10.1016/j.ajog.2014.10.022. PMID: 25446658.
Qatrunnada A, Antonius PA, Yusrawati Y. Faktor Risiko dan Luaran Maternal Plasenta Akreta di RSUP Dr. M. Djamil Padang. Indonesian Journal of Obstetrics & Gynecology Science. 2018 Sep 25;1(2):97–102. doi: 10.24198/obgynia.v1i2.94.
Kasraeian M, Hashemi A, Hessami K, et al. A 5-year experience on perinatal outcome of placenta accreta spectrum disorder managed by cesarean hysterectomy in southern Iranian women. BMC Women’s Health. 2021 Jun 15;21(1):243–8. doi: 10.1186/s12905-021-01389-z. PMID: 34130685; PMCID: PMC8207599.
Del Negro V, Aleksa N, Galli C, et al. Ultrasonographic Diagnosis of Placenta Accreta Spectrum (PAS) Disorder: Ideation of an Ultrasonographic Score and Correlation with Surgical and Neonatal Outcomes. Diagnostics. 2020 Dec 25;11(1):23–32. doi: 10.3390/diagnostics11010023. PMID: 33375532; PMCID: PMC7824485.
Kyozuka H, Yamaguchi A, Suzuki D, et al. Risk factors for placenta accreta spectrum: findings from the Japan environment and Children’s study. BMC Pregnancy and Childbirth. 2019 Nov 27;19(1):447–53. doi: 10.1186/s12884-019-2608-9. PMID: 31775687; PMCID: PMC6882023.
Cunningham FG, Leveno KJ, Bloom SL, et al. Williams Obstetrics. United States of America: Mc Graw Hill Education; 2018. p. 80–110.
Silver R. Placenta Accreta Syndrome. Boca Raton: CRC Press; 2017. p. 13–29.
Kayem G, Seco A, Vendittelli F, et al. Risk factors for placenta accreta spectrum disorders in women with any prior cesarean and a placenta previa or low lying: a prospective population-based study. Scientific Reports. 2024 Mar 19;14(1):6564–71. doi: 10.1038/s41598-024-56964-9. PMID: 38503816; PMCID: PMC10951207.
Bowman ZS, Eller AG, Bardsley TR, et al. Risk factors for placenta accreta: a large prospective cohort. American Journal of Perinatology. 2014 Oct 1;31(9):799–804. doi: 10.1055/s-0033-1361833. PMID: 24338130.
Flo K, Widnes C, Vårtun Å, et al. Blood flow to the scarred gravid uterus at 22-24 weeks of gestation. BJOG: An International Journal of Obstetrics & Gynaecology. 2014 Jan;121(2):210–5. doi: 10.1111/1471-0528.12441. PMID: 24112289.
Jenabi E, Salehi AM, Masoumi SZ, et al. Maternal Smoking and the Risk of Placenta Accreta Spectrum: A Systematic Review and Meta-Analysis. Suneeta M, editor. BioMed Research International. 2022 Jul 11;2022:1–6. doi: 10.1155/2022/2399888. PMID: 35860796; PMCID: PMC9293521.
Guo Z, Han X, Zheng W, et al. Placenta Accreta Spectrum Among Multiple Gestation: A Retrospective Analysis Based on a Chinese Population. Frontiers in endocrinology. 2022 May 18;13. doi: 10.3389/fendo.2022.862785. PMID: 35663330; PMCID: PMC9158523.
Modest AM, Toth TL, Johnson KM, et al. Placenta Accreta Spectrum: In Vitro Fertilization and Non-In Vitro Fertilization and Placenta Accreta Spectrum in a Massachusetts Cohort. American Journal of Perinatology. 2020 Jul 5;38(14):1533–9. doi: 10.1055/s-0040-1713887. PMID: 32623707.
Salmanian B, Fox KA, Arian SE, et al. In vitro fertilization as an independent risk factor for placenta accreta spectrum. American Journal of Obstetrics and Gynecology. 2020 Oct 1;223(4):568.e1–5. doi: 10.1016/j.ajog.2020.04.026. PMID: 32360847.
Vieira MC, Rijken MJ, Braun T, et al. The relation between maternal obesity and placenta accreta spectrum: A multinational database study. Acta obstetricia et gynecologica Scandinavica. 2021 Mar 1;100(S1):50–7. doi: 10.1111/aogs.14075. PMID: 33811335.
Zhang L, Bi S, Du L, Gong J, Chen J, Sun W, et al. Effect of previous placenta previa on outcome of next pregnancy: a 10-year retrospective cohort study. BMC Pregnancy and Childbirth [Internet]. 2020 Apr 15 [cited 2024 Dec 27];20(1). doi: 10.1186/s12884-020-02890-3. PMID: 32293318; PMCID: PMC7161269.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
1. Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
2. The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
3. The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.